Complementary Antiviral Efficacy of Hydroxyurea and Protease Inhibitors in Human Immunodeficiency Virus-Infected Dendritic Cells and Lymphocytes

von Piccinini, Giampiero, Foli, Andrea, Comolli, Giuditta, Lisziewicz, Julianna, Lori, Franco
Veröffentlicht 2002

A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis

von Palladini, Giovanni, Russo, Paola, Milani, Paolo, Foli, Andrea, Lavatelli, Francesca, Nuvolone, Mario, Perlini, Stefano, Merlini, Giampaolo
Veröffentlicht 2013

Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

von Basset, Marco, Milani, Paolo, Nuvolone, Mario, Benigna, Francesca, Rodigari, Lara, Foli, Andrea, Merlini, Giampaolo, Palladini, Giovanni
Veröffentlicht in Blood Adv (2020)

Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach

von Palladini, Giovanni, Milani, Paolo, Foli, Andrea, Obici, Laura, Lavatelli, Francesca, Nuvolone, Mario, Caccialanza, Riccardo, Perlini, Stefano, Merlini, Giampaolo
Veröffentlicht 2014

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy

von Milani, Paolo, Basset, Marco, Nuvolone, Mario, Benigna, Francesca, Rodigari, Lara, Lavatelli, Francesca, Foli, Andrea, Merlini, Giampaolo, Palladini, Giovanni
Veröffentlicht in Blood Cancer J (2020)

Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function

von Milani, Paolo, Basset, Marco, Curci, Paola, Foli, Andrea, Rizzi, Rita, Nuvolone, Mario, Guido, Raffaella, Gesualdo, Loreto, Specchia, Giorgina, Merlini, Giampaolo, Palladini, Giovanni
Veröffentlicht in Blood Adv (2020)

Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences

von Shepard, Brett D., De Forni, Davide, McNamara, David R., Foli, Andrea, Rizza, Stacey A., Abraham, Roshini S., Knutson, Keith, Wettstein, Peter J., Lori, Franco, Badley, Andrew D.
Veröffentlicht 2008

A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

von Sidana, Surbhi, Milani, Paolo, Binder, Moritz, Basset, Marco, Tandon, Nidhi, Foli, Andrea, Dispenzieri, Angela, Gertz, Morie A., Hayman, Suzanne R., Buadi, Francis K., Lacy, Martha Q., Kapoor, Prashant, Leung, Nelson, Rajkumar, S. Vincent, Merlini, Giampaolo, Palladini, Giovanni, Kumar, Shaji K.
Veröffentlicht in Blood Cancer J (2020)

Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis

von Palladini, Giovanni, Paiva, Bruno, Wechalekar, Ashutosh, Massa, Margherita, Milani, Paolo, Lasa, Marta, Ravichandran, Sriram, Krsnik, Isabel, Basset, Marco, Burgos, Leire, Nuvolone, Mario, Lecumberri, Ramón, Foli, Andrea, Puig, Noemi, Sesta, Melania Antonietta, Bozzola, Margherita, Cascino, Pasquale, Nevone, Alice, Ripepi, Jessica, Berti, Pierpaolo, Casarini, Simona, Annibali, Ombretta, Orfao, Alberto, San-Miguel, Jesus, Merlini, Giampaolo
Veröffentlicht in Blood Cancer J (2021)